2
Clinical Trials associated with OCT-461201A Phase I, First-in-human, Randomised, Double-blind, Placebo-controlled, Single Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study to Investigate the Effects of OCT461201 in Healthy Volunteers
A study in healthy volunteers to evaluate the safety, tolerability and pharmacokinetics of OCT461201. The study included a screening period, a single dose of study treatment or placebo and a follow up period.
A Phase I, first-in-human, randomised, double-blind, placebo-controlled, single ascending oral dose, safety, tolerability and pharmacokinetic study to investigate the effects of OCT461201 in healthy volunteers
Start Date22 May 2023 |
Sponsor / Collaborator- |
100 Clinical Results associated with OCT-461201
100 Translational Medicine associated with OCT-461201
100 Patents (Medical) associated with OCT-461201
100 Deals associated with OCT-461201